Ownership

Daniel S. Lorrain - Chief Scientific Officer at Contineum Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Scientific Officer
Stock Symbol: CTNM on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Daniel S. Lorrain - trading volume in the past year for Contineum Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-7.2K	100%	$16.33	-$118K
Net	-7.2K	-100%		-$118K

Holdings reported by Daniel S. Lorrain for Contineum Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Class A Common Stock	169K	$2.7M	$16.02	Nov 25, 2024	Direct
Class A Common Stock	3.9K	$62.4K	$16.02	Nov 25, 2024	By Spouse
Stock Option (right to buy)	100K			May 24, 2024	Direct	Class A Common Stock
Stock Option (right to buy)	3.7K			May 24, 2024	By Spouse	Class A Common Stock

Transactions reported by Daniel S. Lorrain for Contineum Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.